TITLE:
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

CONDITION:
Fatigue

INTERVENTION:
dexmethylphenidate(d-mph)

SUMMARY:

      To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of
      chemotherapy-related fatigue in adult cancer subjects.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        -  Diagnosis of cancer, excluding primary or metastatic brain tumors.

          -  Treated with a minimum of four cycles of a cytotoxic chemotherapy, the last
             chemotherapy treatment must have been completed at least 2 months prior to study
             entry.

          -  Physical/neurological examination consistent with the absence of a focal neurological
             deficit

          -  Women of childbearing potential (WCBP) must have a negative serum or urine pregnancy
             test. In addition, sexually active WCBP must agree to use adequate contraceptive
             methods (oral, injectable, or implantable hormonal contraceptive; tubal ligation;
             intra-uterine device; barrier contraceptive with spermicide; or vasectomized
             partner).

          -  Subjects must be able to adhere to the protocol requirements.

          -  Subjects must understand and voluntarily sign an informed consent document.

          -  Subjects must be a native English speaker or fluent in English, and have at least an
             eighth grade education.
      
